Diagnosis codes for LONSURF use in metastatic colorectal cancer 1
ICD-10-CM | Description |
C18.0 | Malignant neoplasm of cecum |
C18.2 | Malignant neoplasm of ascending colon |
C18.3 | Malignant neoplasm of hepatic flexure |
C18.4 | Malignant neoplasm of transverse colon |
ICD-10-CM | Description |
---|---|
C18.5 | Malignant neoplasm of splenic flexure |
What You Can Do
The following services are considered colorectal cancer screening services:
Metastasis to the colon or rectum is classified to code 197.5. Carcinoma of the colon is assigned to code 230.3 while carcinoma of the rectum goes to 230.4. Patients may not experience any symptoms of early-stage cancer.
Metastatic colon cancer is an advanced-stage malignancy that originated in the colon and has traveled to other areas of the body. While colon cancer can spread anywhere in the body, it most often affects the liver or lungs.
ICD-10-CM Code for Malignant (primary) neoplasm, unspecified C80. 1.
Malignant neoplasm of colon, unspecified C18. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C18. 9 became effective on October 1, 2021.
So colorectal cancer that spreads, or metastasizes, to the lungs, liver or any other organ is called metastatic colorectal cancer. The most common site of metastases for colorectal cancer, which includes colon cancer or rectal cancer is the liver.
The 2022 edition of ICD-10-CM C79. 9 became effective on October 1, 2021. This is the American ICD-10-CM version of C79.
6. When a patient is admitted because of a primary neoplasm with metastasis and treatment is directed toward the secondary site only, the secondary neoplasm is designated as the principal diagnosis even though the primary malignancy is still present.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code Z85. 038 for Personal history of other malignant neoplasm of large intestine is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Z12.11. Encounter for screening for malignant neoplasm of colon.
Patients with hepatic metastasis of colorectal cancer have a median survival of 5 to 20 months with no treatment. Approximately 20 to 30% of patients with colorectal metastasis have disease confined to the liver, and this can be managed with surgery.
Cure is not possible for most patients with metastatic colorectal cancer, although some patients who have limited involvement of distant organs (particularly restricted to the liver and/or lung) can be cured with surgery. For others, chemotherapy is the most appropriate option.
Among people diagnosed with metastatic colorectal cancer, approximately 70% to 75% of patients survive beyond 1 year, 30% to 35% beyond 3 years, and fewer than 20% beyond 5 years from diagnosis.
But if a tumor develops into a carcinoma with the ability to metastasize, it will progress to metastasis quickly. This transformation occurs within about two years, before another mutation can develop.
Coding Information. The following 2021 ICD-10 codes are effective from October 1, 2020 through September 30, 2021. The diagnostic codes contained in this section are designed to provide important reimbursement information that will be helpful for your practice. ICD codes continually change, so it is recommended that you consult your ICD-10 code ...
Pulmonary emboli occurred more frequently in LONSURF‑treated patients compared to placebo: in mCRC (2% vs 0%) and in metastatic gastric cancer and GEJ (3% vs 2%).
If the documentation states the cancer is a metastatic cancer, but does not state the site of the metastasis, the coder will assign a code for the primary cancer, followed by code C79.9 secondary malignant neoplasm of unspecified site.
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80.1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79.51, C80.1.
When coding malignant neoplasms, there are several coding guidelines we must follow:#N#To properly code a malign ant neoplasm, the coder must first determine from the documentation if the neoplasm is a primary malignancy or a metastatic (secondary) malignancy stemming from a primary cancer.
When a current cancer is no longer receiving treatment of any kind, it is coded as a history code. For instance, the patient had breast cancer (C50.xx) and underwent a mastectomy, followed by chemoradiation. The provider documents that the patient has no evidence of disease (NED).
For instance, a patient who has primary breast cancer (C50.xx) who is now seen for metastatic bone cancer will have a code for the secondary bone cancer (C79.51) sequenced before a code for the primary breast cancer (C50.xx). When a current cancer is no longer receiving treatment of any kind, it is coded as a history code.